7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

RUSSIA TO SUPPLY INDIA FIRM WITH 100M DOSES OF SPUTNIK V

7 months ago | World | 0 comments

By Xai Reyes

THE Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), a global pharmaceutical company based in India, have agreed to cooperate on clinical trials and distribution of the Sputnik V vaccine in India.

Upon regulatory approval in India, RDIF shall supply to Dr. Reddy’s 100 million doses of the vaccine.

The Sputnik V vaccine, which is based on a well-studied human adenoviral vector platform with proven safety, is undergoing phase three clinical trials for the coronavirus pandemic.

Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

The RDIF is also in talks with some manufacturers in India for the possible manufacture of the vaccine there.

The agreement between RDIF and Dr. Reddy’s reflects the growing awareness of countries and organizations to have a diversified anti-COVID vaccine portfolio to protect their populations.

“We are very pleased to partner with Dr.Reddy’s in India. Dr. Reddy’s has had a very well established and respected presence in Russia for over 25 years and is one of the leading pharmaceutical companies in India,” said RDIF chief executive officer Kirill Dmitriev.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media